CORTEF ACETATE Drug Patent Profile
✉ Email this page to a colleague
When do Cortef Acetate patents expire, and what generic alternatives are available?
Cortef Acetate is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.
The generic ingredient in CORTEF ACETATE is hydrocortisone acetate. There are sixty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CORTEF ACETATE?
- What are the global sales for CORTEF ACETATE?
- What is Average Wholesale Price for CORTEF ACETATE?
Summary for CORTEF ACETATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,812 |
| DailyMed Link: | CORTEF ACETATE at DailyMed |
Recent Clinical Trials for CORTEF ACETATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University Medical Center Groningen | Early Phase 1 |
US Patents and Regulatory Information for CORTEF ACETATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | CORTEF ACETATE | hydrocortisone acetate | INJECTABLE;INJECTION | 009378-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | CORTEF ACETATE | hydrocortisone acetate | OINTMENT;TOPICAL | 008917-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | CORTEF ACETATE | hydrocortisone acetate | OINTMENT;TOPICAL | 008917-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
